Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo” or the “Firm”) today announced the creation of an Impact
FDA approves Oncopeptides PEPAXTO ( melphalan flufenamide) for patients with relapsed or refractory multiple myeloma
STOCKHOLM, Feb. 26, 2021 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO
), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announced that the U.S. Food and Drug Administration, FDA, has approved PEPAXTO (melphalan flufenamide, also known as melflufen), in combination with dexamethasone, for the treatment of adult patients with relapsed or refractory multiple myeloma, who have received at least four prior lines of therapy and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one CD38-directed monoclonal antibody.
FDA approves Oncopeptides PEPAXTO® ( melphalan flufenamide) for patients with relapsed or refractory multiple myeloma prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Apollo Appoints Jay Clayton as Lead Independent Director
Nachrichtenquelle: globenewswire | 18.02.2021, 12:30 | 120
Appointment is Latest Step in Firm’s Corporate Governance Enhancements NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE) Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo” or the “Firm”) today announced that Jay Clayton has been appointed to serve as Lead Independent Director of its Board of Directors, effective March 1, 2021. Mr. Clayton assumes this newly created role following his service as Chair of the U.S. Securities and Exchange Commission (“SEC”) from May 2017 through December 2020. Mr. Clayton was selected for this important role due to the exceptional breadth of his professional experience, as well as his deep knowledge and understanding of private and public capital
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Athene and Funds Affiliated with Apollo to Sell AmeriHome to Western Alliance Bank
Apollo Global Management, Inc.; Athene Holding Ltd., AmeriHome Mortgage Company, LLCFebruary 16, 2021 GMT
NEW YORK, HAMILTON, Bermuda, and THOUSAND OAKS, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo”), Athene Holding Ltd. (NYSE: ATH) (“Athene”), and AmeriHome Mortgage Company, LLC, the nation’s third largest correspondent mortgage acquirer (“AmeriHome”), today announced the execution of a definitive agreement to sell AmeriHome to a subsidiary of Western Alliance Bancorporation (NYSE: WAL) (“Western Alliance”).